Join the Atrial Fibrillation group to help and get support from people like you.
Atrial Fibrillation News (Page 4)
Related terms: A-fib, Paroxysmal Atrial Fibrillation, PAF, AFib, AF
Fast-Acting Investigational Nasal Spray May Ease Rapid Heartbeat
WEDNESDAY, Sept. 27, 2023 – Up to 2 million people in the U.S. experience rapid-fire heartbeats from time to time, and many end up in the hospital for treatment. But an investigational nasal spray...
Hypoattenuation Thickening on CT Prognostic After Left Atrial Appendage Occlusion
WEDNESDAY, Sept. 13, 2023 – For patients with atrial fibrillation undergoing left atrial appendage occlusion (LAAO), high-grade hypoattenuation thickening (HAT) at follow-up computed tomography (CT)...
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 – For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a...
Psychosocial Stressors Tied to Incident Atrial Fibrillation in Postmenopausal Women
FRIDAY, Sept. 1, 2023 – Among postmenopausal women, two clusters of psychosocial stressors are significantly associated with incident atrial fibrillation (AF), according to a study published online...
More Stress, Higher Odds for A-Fib in Women After Menopause
THURSDAY, Aug. 31, 2023 – Postmenopausal women who are stressed, depressed or have trouble sleeping may face an increased risk of a common heart rhythm disorder, new research suggests. The study, of...
ESC: Catheter Ablation Aids Symptomatic Atrial Fibrillation, End-Stage Heart Failure
WEDNESDAY, Aug. 30, 2023 – For patients with atrial fibrillation and end-stage heart failure, the combination of catheter ablation and guideline-directed medical therapy is associated with a lower...
Catheter Ablation for Atrial Fibrillation Cuts Risk for Dementia, Death
FRIDAY, Aug. 25, 2023 – In patients with atrial fibrillation (AF), those undergoing catheter ablation have a lower risk for incident dementia and mortality, according to a study published online...
Stay Fit to Avoid A-Fib and Stroke
TUESDAY, Aug. 22, 2023 – People can help reduce their odds of developing atrial fibrillation or stroke through one piece of standard medical advice: stay fit. According to a new study in 15,000...
FDA Approves Savaysa (edoxaban) to Prevent Embolic Events in Non-Valvular Atrial Fibrillation
January 8, 2015 – The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in...
Arbor Pharmaceuticals Announces FDA Approval of Sotylize
Atlanta, GA — October 23,2014 – Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Sotylize (sotalol h...
FDA Approves Eliquis to Reduce the Risk of Stroke, Blood Clots in Patients with Non-Valvular Atrial Fibrillation
December 28, 2012 – The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots...
FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation
SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
metoprolol, propranolol, Xarelto, clonidine, carvedilol, diltiazem, digoxin, flecainide, sotalol, Coreg